CHILLA', ANASTASIA
 Distribuzione geografica
Continente #
EU - Europa 2.662
NA - Nord America 2.612
AS - Asia 487
AF - Africa 16
OC - Oceania 1
SA - Sud America 1
Totale 5.779
Nazione #
US - Stati Uniti d'America 2.608
PL - Polonia 1.114
RU - Federazione Russa 703
IT - Italia 287
IE - Irlanda 189
SE - Svezia 188
SG - Singapore 124
CN - Cina 119
HK - Hong Kong 97
JO - Giordania 72
GB - Regno Unito 45
IN - India 35
FI - Finlandia 31
VN - Vietnam 28
BE - Belgio 25
DE - Germania 25
CH - Svizzera 14
CI - Costa d'Avorio 13
AT - Austria 11
FR - Francia 10
ES - Italia 8
TR - Turchia 6
UA - Ucraina 6
KR - Corea 4
NL - Olanda 4
CA - Canada 3
NO - Norvegia 2
TN - Tunisia 2
AM - Armenia 1
AU - Australia 1
CL - Cile 1
CR - Costa Rica 1
MU - Mauritius 1
PH - Filippine 1
Totale 5.779
Città #
Warsaw 1.114
Santa Clara 482
Fairfield 312
Chandler 245
Dublin 189
Ashburn 170
Ann Arbor 149
Woodbridge 139
Seattle 125
Houston 120
Cambridge 113
Florence 111
Singapore 100
Wilmington 94
Hong Kong 65
Altamura 59
Lawrence 58
Princeton 46
Beijing 38
Moscow 38
Shanghai 31
Buffalo 28
Mumbai 26
Boston 25
Brussels 25
Boardman 22
Medford 21
Dong Ket 18
San Diego 18
Bern 14
Abidjan 13
Kent 11
Vienna 11
Jacksonville 10
Norwalk 9
Barcelona 8
New York 8
Phoenix 8
Zhengzhou 8
Helsinki 7
Hillsboro 7
Bari 6
Izmir 6
Pune 6
Fiesole 5
Los Angeles 5
Redmond 5
Yubileyny 5
Bremen 4
Guangzhou 4
London 4
Milan 4
Prato 4
West Jordan 4
Cecina 3
Chiusi 3
Council Bluffs 3
Grafing 3
Hangzhou 3
Palaiseau 3
Poggio a Caiano 3
Rome 3
Toronto 3
Amsterdam 2
Bientina 2
Bologna 2
Castel Ritaldi 2
Falls Church 2
Formigine 2
Frankfurt Am Main 2
Newark 2
Oslo 2
Pian di Scò 2
Pisa 2
Romola 2
Seoul 2
Shenzhen 2
Tappahannock 2
Tunis 2
Wuhan 2
Acton 1
Andover 1
Avellino 1
Bagno A Ripoli 1
Baoding 1
Birmingham 1
Brescia 1
Castelliri 1
Catania 1
Cedar Knolls 1
Changchun 1
Chiswick 1
Dalian 1
Fabriano 1
Fort Worth 1
Frankfurt am Main 1
Genoa 1
Grevenbroich 1
Groningen 1
Gwanak-gu 1
Totale 4.238
Nome #
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 288
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 286
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 284
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 258
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 255
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 238
Type II CRISPR/Cas9 approach in the oncological therapy 231
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 214
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 188
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 173
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 157
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 154
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 153
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 151
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 146
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 144
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 142
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 141
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 130
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 122
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 119
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 114
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 113
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 105
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 104
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 101
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 100
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 99
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 79
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 79
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 79
Chronic treatment with resveratrol and olive oil phenols on MRC5 fibroblast SASP: inhibition of pro-tumoral microenvironment 73
Delivery systems of CRISPR/Cas9-based cancer gene therapy 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 73
Plasticity in Endothelial Cells and Endothelial Progenitor Cells: uPAR-mediated Amoeboid Angiogenesis 70
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 70
Olive phenols preserve lamin B1 expression reducing cGAS/STING/NFκB-mediated SASP in ionizing radiation-induced senescence. 67
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 66
Th17 lymphocyte-dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab 66
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8 63
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 62
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy 62
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 60
Water diffusion effects at gold-graphene interfaces supporting surface plasmon polaritons 54
Pulsed-Laser-Driven CO2 Reduction Reaction for the Control of the Photoluminescence Quantum Yield of Organometallic Gold Nanocomposites 34
Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways 32
Effects of cilengitide in osteoclast maturation and behavior 29
PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis 26
Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts. 25
Tipifarnib as a precision therapy for HRAS-mutant head and neck squamous cell carcinomas 22
Totale 5.901
Categoria #
all - tutte 15.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020640 0 0 0 0 100 80 79 116 85 72 95 13
2020/2021749 47 98 20 94 49 57 50 53 63 140 38 40
2021/2022343 16 28 25 20 17 11 16 29 18 17 61 85
2022/20231.012 83 221 38 85 73 155 113 70 121 6 25 22
2023/2024417 7 38 46 12 23 81 22 91 6 44 27 20
2024/20251.529 94 261 156 397 621 0 0 0 0 0 0 0
Totale 5.901